Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dietary nonheme iron is the form of iron found predominantly in plant-based foods, enriched products, and supplements, contrasted with heme iron that is present in animal foods. Nonheme iron is mainly present as ferric iron (Fe³⁺), which must be reduced to the ferrous form (Fe²⁺) via gastric acid and the ferric reductase enzyme (duodenal cytochrome B, Dcytb) prior to absorption by enterocytes in the duodenum, primarily via the divalent metal transporter 1 (DMT1)[2][5][6][7]. Absorption efficiency is low (5–12% for strict plant diets, up to 17% with mixed diets), and many dietary compounds (phytates, polyphenols, calcium, oxalate) inhibit its uptake. Ascorbic acid markedly enhances absorption by forming soluble iron chelates and reducing ferric iron to ferrous iron, which is the bioavailable form for enterocytes[1][3][6][7]. Dietary nonheme iron is crucial for preventing iron deficiency anemia and supporting normal hematopoiesis and metabolism, but it is not a protein or receptor that can be pharmacologically targeted[3][5].
Not applicable; no drugs act via "targeting" dietary nonheme iron as a molecule
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dietary nonheme iron.